title: Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®).
authors: Department of Neurology, University of Rostock, Germany. Electronic address: christoph.kamm@med.uni-rostock.de.
authors: Christoph
authors: C
authors: Kamm
authors: Department of Neurology, University of Rostock, Germany.
authors: Friederike
authors: F
authors: Schümann
authors: Department of Neurology, University of Rostock, Germany.
authors: Eilhard
authors: E
authors: Mix
authors: Department of Neurology, University of Rostock, Germany.
authors: Reiner
authors: R
authors: Benecke
mesh_terms: D001323:Autoantibodies / Q000009:adverse effects*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000009:adverse effects*; D020821:Dystonic Disorders / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D019274:Botulinum Toxins, Type A; C542869:abobotulinumtoxinA; C545476:incobotulinumtoxinA